Fluoroquinolone Resistance in Salmonella Typhi and S. Paratyphi a in Bangalore, India.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A is being increasingly reported. The minimum inhibitory concentrations (MICs) of ciprofloxacin, ofloxacin, levofloxacin and gatifloxacin against S. typhi and S. paratyphi A were compared. Fifty blood culture isolates, 25 S. typhi and 25 S. paratyphi A, were studied.
S, Joshi, S K, Amarnath
exaly +3 more sources
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi a Vaccine [PDF]
BACKGROUND Salmonellaenterica serovar Paratyphi A (also known as S. Paratyphi A) is responsible for more than 2 million cases of enteric fever annually. There are no licensed vaccines against S. Paratyphi A.
Naina McCann +2 more
exaly +3 more sources
Spontaneous bacterial peritonitis caused by S. paratyphi A.
The Journal of the Association of Physicians of India, 2014Spontaneous (primary) bacterial peritonitis (SBP) due to S. paratyphi A is relatively uncommon. Clinical manifestations of SBP vary widely from severe to slight or absent, necessitating laboratory investigation of ascitic fluid. The disease is confirmed by number of neutrophils > 250/mm3 associated with or without bacterial growth in ascitic fluid ...
Ranjeeta, Adhikary +3 more
openaire +1 more source
THE BIOGRAPHY OF A BACTERIA ̶ S. PARATYPHI ERZINCAN (NEUKIRCH)
2018Dr. Paul Richard Neukirch (1885-1962) was one of thephysicians at the German Red Cross mission for Erzincan, Turkey instated inFebruary 1915. Here Dr. Neukirch diagnosed the Bacillus Erzincan(Erzindjan) in certain clinical forms of paratyphoid fever. He returned to theGerman Red Cross Hospital Istanbul in the fall of 1915 to continue his researchon the
openaire +1 more source
Consultation Report – Considerations for a Regulatory Pathway for Bivalent Salmonella Typhi/Paratyphi a Vaccines for Use in Endemic Countries [PDF]
Enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi A and, to a lesser extent, S. Paratyphi B and C, remains a significant cause of mortality and morbidity in resource-constrained settings.
John, J +13 more
exaly +2 more sources
Behaviour of S. paratyphi A in mice immunized with homologous and heterologous bacterial proteins.
Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie, 1979Mice immunized with proteins from S. typhimurium and from S. paratyphi C resisted the toxicity of a concentration of S. paratyphi A which killed the controls; this is in contrast to the results found in mice immunized with the same amount of proteins from the homologous S. paratyphi A. For the neutralization of the S.
E, Eylan, C, Barber
openaire +1 more source
M J, Modak, S, Nair, A, Venkataraman
openaire +1 more source
[Treatment of S. typhi and S. paratyphi B carriers].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1973C, Tauchnitz, M, Horn, E, Förster
openaire +1 more source
Ciprofloxacin and azithromycin resistant S. paratyphi A presenting as relapse.
2014R.A. Corrigan, M.M. Raza
openaire +1 more source
Antibacterial screening of Five Nigerian Medicinal Plants Against S. Typhi and S. Paratyphi
2000The water and ethanol extracts of five Nigerian medicinal plants: Enantia chlorantha, Terminalia avicennioides, Momordica balsamina, Morinda lucida and mangifera indica used traditionally in treating several ailment of both microbial and non- microbial origins were tested on clinical isolates of salmonella typhi and S. paratyphi. Enantia chlorantha and
openaire +1 more source

